院外心脏骤停中骨内与静脉给药复苏的比较
该回顾性队列研究纳入2012年9月1日至2014年12月31日某大型都市急救系统治疗的成人非创伤性院外心脏骤停患者2164例,其中1800例符合标准,1525例主要经静脉给药、275例主要经胫骨骨内给药。骨内组患者更年轻、女性更多、更多为无人目击心脏骤停、非心源性病因及不可电击心律。骨内组较静脉组出院存活率更低(14.9% vs 22.8%,p=0.003)、自主循环恢复率更低(43.6% vs 55.5%,p<0.001)、住院率更低(38.5% vs 50.0%,p<0.001)。多变量校正后,骨内途径与出院存活无独立关联(OR 0.81,95%CI 0.55-1.21,p=0.31),但与自主循环恢复率更低(OR 0.67,95%CI 0.50-0.88,p=0.004)和住院存活率更低(OR 0.68,95%CI 0.51-0.91,p=0.009)相关。作者认为血管通路途径如何影响院外心脏骤停后临床结局值得进一步研究。
要点
- 在1800例成人非创伤性院外心脏骤停中,主要经胫骨骨内给药者275例,主要经静脉给药者1525例。
- 骨内组较静脉组出院存活率更低(14.9% vs 22.8%,p=0.003)。
- 骨内组较静脉组自主循环恢复率更低(43.6% vs 55.5%,p<0.001)。
- 多变量校正后,骨内途径与出院存活无独立关联(OR 0.81,95%CI 0.55-1.21,p=0.31)。
- 多变量校正后,骨内途径与自主循环恢复率更低(OR 0.67,95%CI 0.50-0.88,p=0.004)及住院存活率更低(OR 0.68,95%CI 0.51-0.91,p=0.009)相关。
适用人群与场景
- 2012年9月1日至2014年12月31日某大型都市急救系统治疗的成人非创伤性院外心脏骤停患者。
- 纳入2164例成人院外心脏骤停,1800例符合 eligibility 标准;其中1525例主要经静脉给药,275例主要经胫骨骨内给药。
研究设计与关键结果
- 研究类型为回顾性队列研究,样本量1800例符合标准,人群为急救系统治疗的成人非创伤性院外心脏骤停患者,比较主要经胫骨骨内给药(275例)与主要经静脉给药(1525例)。
- 骨内组较静脉组出院存活率更低(14.9% vs 22.8%,p=0.003)。
- 骨内组较静脉组自主循环恢复率更低(43.6% vs 55.5%,p<0.001)。
- 骨内组较静脉组住院率更低(38.5% vs 50.0%,p<0.001)。
- 多变量校正分析中,骨内途径与出院存活无独立关联(OR 0.81,95%CI 0.55-1.21,p=0.31)。
- 多变量校正分析中,骨内途径与自主循环恢复率更低相关(OR 0.67,95%CI 0.50-0.88,p=0.004)。
- 多变量校正分析中,骨内途径与住院存活率更低相关(OR 0.68,95%CI 0.51-0.91,p=0.009)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,血管通路途径如何影响院外心脏骤停后临床结局值得进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: Although the intraosseous (IO) route is increasingly used for vascular access in out-of-hospital cardiac arrest (OHCA), little is known about its comparative effectiveness relative to intravenous (IV) access. We evaluated clinical outcomes following OHCA comparing drug administration via IO versus IV routes.
METHODS: This retrospective cohort study evaluated Emergency Medical Services (EMS)-treated adults with atraumatic OHCA in a large metropolitan EMS system between 9/1/2012-12/31/2014. Access was classified as IO or IV based on the route of first EMS drug administration. Study endpoints were survival to hospital discharge, return of spontaneous circulation (ROSC) and survival to hospital admission.
RESULTS: Among 2164 adults with OHCA, 1800 met eligibility criteria, 1525 of whom were treated via IV and 275 principally via tibial-IO routes. Compared to IV, IO-treated patients were younger, more often women, had unwitnessed OHCA, a non-cardiac aetiology, and presented with non-shockable rhythms. IO versus IV-treated patients were less likely to survive to hospital discharge (14.9% vs 22.8%, p=0.003), achieve ROSC (43.6% vs 55.5%, p<0.001) or be hospitalized (38.5% vs 50.0% p<0.001). In multivariable adjusted analyses, IO treatment was not associated with survival to discharge (odds ratio (OR) (95% confidence interval) 0.81 (0.55, 1.21), p=0.31), but was associated with a lower likelihood of ROSC (OR=0.67 (0.50, 0.88), p=0.004) and survival to hospitalization (OR=0.68 (0.51, 0.91), p=0.009).
CONCLUSION: Though not independently associated with survival to discharge, principally tibial IO versus IV treatment was associated with a lower likelihood of ROSC and hospitalization. How routes of vascular access influence clinical outcomes after OHCA merits additional study.
参考来源
- Feinstein BA, Stubbs BA, Rea T, et al. Intraosseous compared to intravenous drug resuscitation in out-of-hospital cardiac arrest. Resuscitation. 2017. PMID: 28629995. doi:10.1016/j.resuscitation.2017.06.014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。